XML 43 R32.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair Value (Tables)
9 Months Ended
Sep. 30, 2016
Fair Value Disclosures [Abstract]  
Financial Assets and Liabilities Measured at Fair Value on Recurring Basis
The following fair value hierarchy table presents information about the Company’s financial assets and liabilities measured at fair value (in thousands):
 
 
Assets and Liabilities Measured at
Fair Value on a Recurring Basis
September 30, 2016
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets
 
 
 
 
 
 
 
 
Financial instruments owned, at fair value:
 
 
 
 
 
 
 
 
Equities
 
$
2,641,499

 
$

 
$

 
$
2,641,499

Corporate debt
 
179,152

 

 

 
179,152

U.S. government obligations
 
72,112

 

 

 
72,112

Listed options
 
12,190

 

 

 
12,190

Total Financial instruments owned, at fair value
 
2,904,953

 

 

 
2,904,953

Investment in CME Group (1)
 
2,093

 

 

 
2,093

Other (2)
 

 
62,151

 
6,650

 
68,801

Total assets held at fair value
 
$
2,907,046

 
$
62,151

 
$
6,650

 
$
2,975,847

Liabilities
 

 
 
 

 

Financial instruments sold, not yet purchased, at fair value:
 
 
 
 
 
 
 
 
Equities
 
$
1,927,864

 
$

 
$

 
$
1,927,864

Corporate debt
 
173,678

 

 

 
173,678

U.S. government obligations
 
104,625

 

 

 
104,625

Listed options
 
16,319

 

 

 
16,319

Foreign currency forward contracts
 

 
302

 

 
302

Total liabilities held at fair value
 
$
2,222,486

 
$
302

 
$

 
$
2,222,788


(1) 
Investment in CME Group is included within Investments on the Consolidated Statements of Financial Condition. See Footnote 8 "Investments" for additional information.
(2) 
Other primarily consists of a $59.9 million receivable from Bats related to the sale of KCG Hotspot and a $6.7 million receivable from the sale of an investment, both of which are included within Other Assets, and $2.3 million of deferred compensation investments which is included within Investments on the Consolidated Statements of Financial Condition.

 
 
Assets and Liabilities Measured at
Fair Value on a Recurring Basis
December 31, 2015
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets
 
 
 
 
 
 
 
 
Financial instruments owned, at fair value:
 
 
 
 
 
 
 
 
Equities
 
$
2,129,208

 
$

 
$

 
$
2,129,208

Listed options
 
178,360

 

 

 
178,360

U.S. government and Non-U.S. government obligations
 
41,706

 

 

 
41,706

Corporate debt
 
94,681

 

 

 
94,681

Foreign currency forward contracts
 

 
445

 

 
445

Total Financial instruments owned, at fair value
 
2,443,955

 
445

 

 
2,444,400

Investment in CME Group (1)
 
1,814

 

 

 
1,814

Other (2)
 

 
65,732

 
5,789

 
71,521

Total assets held at fair value
 
$
2,445,769

 
$
66,177

 
$
5,789

 
$
2,517,735

Liabilities
 
 
 
 
 
 
 
 
Financial instruments sold, not yet purchased, at fair value:
 
 
 
 
 
 
 
 
Equities
 
$
1,856,171

 
$

 
$

 
$
1,856,171

Listed options
 
151,893

 

 

 
151,893

U.S. government obligations
 
21,056

 

 

 
21,056

Corporate debt
 
84,284

 

 

 
84,284

Total liabilities held at fair value
 
$
2,113,404

 
$

 
$

 
$
2,113,404


(1) 
Investment in CME Group is included within Investments on the Consolidated Statements of Financial Condition. See Footnote 8 "Investments" for additional information.
(2) 
Other primarily consists of a $64.2 million receivable from Bats related to the sale of KCG Hotspot and a $5.8 million receivable from the sale of an investment, both of which are included in Other assets, and $1.5 million of deferred compensation investments which is included within Investments on the Consolidated Statements of Financial Condition.
Changes in Fair Value of Financial Assets Categorized within Level 3
The following is a summary of changes in fair value of the Company's financial assets that have been categorized within Level 3 of the fair value hierarchy at September 30, 2016 (in thousands):
 
Level 3 Financial Assets for the three months ended September 30, 2016
 
Balance at July
1, 2016
 
Realized gains(losses) during period
 
Unrealized gains (losses) during the period
 
Purchases
 
Sales
 
Settlements
 
Issuances
 
Transfers in or (out) of Level 3
 
Balance at September 30, 2016
Receivable from sold investment
$
6,347

 
$

 
$
303

 
$

 
$

 
$

 
$

 
$

 
$
6,650

 
Level 3 Financial Assets for the nine months ended September 30, 2016
 
Balance at January 1, 2016
 
Realized gains(losses) during period
 
Unrealized gains (losses) during the period
 
Purchases
 
Sales
 
Settlements
 
Issuances
 
Transfers in or (out) of Level 3
 
Balance at September 30, 2016
Receivable from sold investment
$
5,789

 
$

 
$
861

 
$

 
$

 
$

 
$

 
$

 
$
6,650